Answers are grounded in this paper and cite their sources.
Investigation reveals the impact of antiplatelet therapy on clinical outcomes in VTE patients, indicating the need for more data.
Background: Direct oral anticoagulants (DOACs) are commonly used oral anticoagulants for patients with venous thromboembolism (VTE). Sometimes these patients receive concomitant antiplatelet therapy, with limited data supporting the practice. This study investigated the effect of concomitant antiplatelet therapy (CAT) on clinical outcomes in VTE patients treated with anticoagulants.
No takes yet. Share an insight, caveat, or question.
Kaneda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: